KELLY JOHN ALEXANDER (Interim CFO) sold 16.8% of their position (14.83K shares) of PRECISION BIOSCIENCES INC on the open market
Open‑market sale worth $63.2K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/8/2025ACC: 0001628280-25-034531
Officer· Interim CFO
Since Jan 2021
-14.83K
Net shares
Net seller
$63.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
14.83K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−14.83K
Price / share
$4.26
Trade value
$63.16K
% of position
16.8%
7/3/2025
88.31K→73.48K
Total
Net shares
−14.83K
Net value
-$63.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/3/2025 | S · Sale | −14.83K | $4.26 | $63.16K | 16.8% | 88.31K | 73.48K |
| Total | −14.83K | -$63.16K | ||||||
Derivative Transactions0
No derivative transactions reported